Company intelligence / Profile preview
Anhui Leiyunshang Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Lei Yunshang is one of China’s oldest and most respected traditional Chinese medicine companies, with nearly 300 years of history. It produces and markets a wide range of traditional medicines for liver disease, cardiovascular/cerebrovascular conditions, oncology, respiratory health, urology, orthopedics, gastroenterology and metabolic disorders. The company integrates modern R&D with heritage practices and operates GMP-certified manufacturing facilities.
- Therapeutic areas
- Men's HealthPulmonologyOncologyOtherGastroenterologyCardiovascular
- Modalities
- Small moleculeHerbal medicineTraditional Chinese medicine preparation
- Industry
- Pharma
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Anhui Leiyunshang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anhui Leiyunshang Pharmaceutical.